Updated April 2021 8%. That is the five-year survival rate for someone diagnosed with pancreatic cancer in Canada. This disease waits for no one, so neither do we – even amidst a global pandemic. For over 40 years there has been a “one size fits...
Today I am thrilled to announce the launch of our next landmark research investment, PASS-01: a clinical trial that will finally address the diverse nature of this disease and provide personalized treatment options for advanced pancreatic cancer patients....
For several months the COVID-19 crisis has caused many research projects to slow, but Pancreatic Cancer Canada’s research program has not been idle. We have taken this time to quietly prepare for our next big project, because even in the midst of...
April 2020 Pancreatic cancer doesn’t stop…neither do we. It is very hard to see the news right now. Things feel uncertain and unnerving, leaving us to grapple with what will come next. For so many of you and your loved ones, this is not the only desperate time you...
Recent Comments